Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
MARS provides digital financial services with unique card options and rewards programs.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Ambros Therapeutics is a clinical-stage biotechnology company.
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Tasso is a Medical innovation company changing the way diagnostics are delivered
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Belite Bio is a clinical stage biopharmaceutical drug development company.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Life Science. The firm invests across 20 different industry categories.
Among tracked funding rounds, New Amsterdam Pharma received $452.6M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include Wave Life Sciences, Nautilus Biotechnology, 89bio, Emergence Therapeutics, MARS. These companies were founded in 2020 or later.